10-Q 1 d10q.htm FORM 10-Q Form 10-Q
Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 

(Mark One)

 

x   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

 

For the quarterly period ended September 30, 2003.

 

OR

 

¨   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the transition period from _____________ to _____________.

 

Commission file number 000-31173

 


 

ChipPAC, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware   77-0463048

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

 

47400 Kato Road, Fremont, California 94538

(Address of Principal Executive Offices, Zip Code)

 

Registrant’s Telephone Number, Including Area Code (510) 979-8000

 


 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b.2 of the Act). Yes x No ¨

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

 

Class


 

Outstanding as of November 10, 2003


Class A common stock, $.01 par value   97,030,964
Class B common stock, $.01 par value   None

 



Table of Contents

TABLE OF CONTENTS

 

          Page

PART I    FINANCIAL INFORMATION

    

        Item 1.

   Financial Statements     
     Unaudited Condensed Consolidated Balance Sheets    3
     Unaudited Condensed Consolidated Statements of Operations    4
     Unaudited Condensed Consolidated Statements of Cash Flows    5
     Notes to Unaudited Condensed Consolidated Financial Statements    6

        Item 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations    19

        Item 3.

   Quantitative and Qualitative Disclosures About Market Risk    22

        Item 4.

   Controls and Procedures    22

PART II    OTHER INFORMATION

    

        Item 1.

   Legal Proceedings    23

        Item 2.

   Changes in Securities and Use of Proceeds    23

        Item 3.

   Defaults Upon Senior Securities    23

        Item 4.

   Submission of Matters to a Vote of Security Holders    23

        Item 5.

   Other Information    23

        Item 6.

   Exhibits and Reports on Form 8-K    23

         Signatures

   27

        Certifications

    

 

2


Table of Contents

ChipPAC, Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts)

(Unaudited)

 

     September 30,
2003


    December 31,
2002


 
ASSETS                 

Current assets:

                

Cash and cash equivalents

   $ 38,090     $ 34,173  

Short-term investments

     43,022       10,000  

Accounts receivable, less allowances for doubtful accounts of $455 and $391

     44,891       38,793  

Inventories

     20,941       15,299  

Prepaid expenses and other current assets

     9,100       5,285  
    


 


Total current assets

     156,044       103,550  

Property, plant and equipment, net

     360,110       336,397  

Intangible assets, net

     15,949       17,300  

Other assets

     18,913       12,957  
    


 


Total assets

   $ 551,016     $ 470,204  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY                 

Current liabilities:

                

Accounts payable

   $ 48,910     $ 39,755  

Accrued expenses and other current liabilities

     25,714       29,400  
    


 


Total current liabilities

     74,624       69,155  

Long-term debt

     165,000       217,887  

Convertible subordinated notes

     200,000       50,000  

Other long-term liabilities

     21,528       17,618  
    


 


Total liabilities

     461,152       354,660  
    


 


Stockholders’ equity :

                

Common stock, Class A—par value $0.01 per share; 250,000 shares authorized, 96,606 and 94,093 shares issued and outstanding at September 30, 2003 and December 31, 2002, respectively

     966       941  

Additional paid-in capital

     283,017       276,916  

Receivables from stockholders

     (241 )     (480 )

Accumulated other comprehensive income

     9,169       9,169  

Accumulated deficit

     (203,047 )     (171,002 )
    


 


Total stockholders’ equity

     89,864       115,544  
    


 


Total liabilities and stockholders’ equity

   $ 551,016     $ 470,204  
    


 


 

 

The accompanying notes are an integral part of these financial statements.

 

3


Table of Contents

ChipPAC, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)

 

    

For the Three Months

Ended

September 30,


   

For the Nine Months

Ended

September 30,


 
     2003

    2002

    2003

    2002

 

Revenue

   $ 105,420     $ 94,659     $ 300,832     $ 270,958  

Cost of revenue

     92,385       78,699       261,169       227,679  
    


 


 


 


Gross profit

     13,035       15,960       39,663       43,279  
    


 


 


 


Operating expenses:

                                

Selling, general and administrative

     10,313       9,362       28,244       28,982  

Research and development

     2,729       2,550       8,689       7,258  

Restructuring charge and write-down of impaired assets

     13,619             13,619        
    


 


 


 


Total operating expenses

     26,661       11,912       50,552       36,240  
    


 


 


 


Operating income (loss)

     (13,626 )     4,048       (10,889 )     7,039  

Non-operating (income) expenses:

                                

Interest expense

     7,914       7,691       22,804       24,479  

Interest income

     (287 )     (242 )     (596 )     (455 )

Foreign currency (gains) losses

     303       (547 )     519       860  

Gain on sale of building

     (3,929 )           (3,929 )      

Loss from early debt extinguishment

                 1,182       3,005  

Other income, net

     (208 )     (175 )     (324 )     (478 )
    


 


 


 


Total non-operating expenses

     3,793       6,727       19,656       27,411  
    


 


 


 


Loss before income taxes

     (17,419 )     (2,679 )     (30,545 )     (20,372 )

Provision for income taxes

     500       500       1,500       1,500  
    


 


 


 


Net loss

   $ (17,919 )   $ (3,179 )   $ (32,045 )   $ (21,872 )
    


 


 


 


Net loss per share:

                                

Net loss per share available to common stockholders

                                

Basic

   $ (0.19 )   $ (0.03 )   $ (0.34 )   $ (0.26 )

Diluted

   $ (0.19 )   $ (0.03 )   $ (0.34 )   $ (0.26 )

Weighted average shares used in per share calculation:

                                

Basic

     95,710       93,421       95,065       85,166  

Diluted

     95,710       93,421       95,065       85,166  

 

 

The accompanying notes are an integral part of these financial statements.

 

4


Table of Contents

ChipPAC, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

     For the Nine Months
Ended September 30,


 
     2003

    2002

 

Cash flows from operating activities:

                

Net loss

   $ (32,045 )   $ (21,872 )

Adjustments to reconcile net loss to net cash provided by operating activities:

                

Depreciation and amortization

     50,879       42,947  

Amortization of debt issuance costs

     1,584       1,832  

Foreign currency losses

     519       860  

Write-down of impaired assets

     11,662        

Loss from early debt extinguishment

     1,182       3,005  

Gain on sale of building

     (3,929 )      

Gain on sale of equipment

     (371 )     (65 )

Changes in assets and liabilities:

                

Accounts receivable

     (6,098 )     (5,849 )

Inventories

     (5,642 )     (3,552 )

Prepaid expenses and other current assets

     (3,898 )     (1,587 )

Other assets

     (3,320 )     (4,857 )

Accounts payable

     9,155       4,021  

Accrued expenses and other current liabilities

     (3,686 )     (27 )

Other long-term liabilities

     1,824       4,796  
    


 


Net cash provided by operating activities

     17,816       19,652  
    


 


Cash flows from investing activities:

                

Purchases of short-term investments

     (154,618 )      

Proceeds from sale of short-term investments

     121,596        

Acquisition of property and equipment

     (75,660 )     (57,999 )

Acquisition of intangible assets

     (2,279 )     (2,544 )

Proceeds from sale of building

     5,399        

Proceeds from sale of equipment

     479       86  

Acquisition of test assets

     (3,500 )      

Malaysian acquisition, net of cash and cash equivalents acquired

     (3,475 )     (5,873 )
    


 


Net cash used in investing activities

     (112,058 )     (66,330 )
    


 


Cash flows from financing activities:

                

Proceeds from revolving loan and other lines of credit

     27,704       105,596  

Repayment of revolving loan and other lines of credit

     (27,704 )     (105,596 )

Debt issuance costs

     (180 )     (703 )

Net proceeds from long-term debt

     144,861       16,700  

Repayment of long-term debt

     (52,887 )     (82,440 )

Repayment of notes from stockholders

     239       505  

Proceeds from common stock issuance

     6,126       167,105  

Repurchase of common stock

           (24 )
    


 


Net cash provided by financing activities

     98,159       101,143  
    


 


Net increase in cash

     3,917       54,465  

Cash and cash equivalents at beginning of period

     34,173       41,872  
    


 


Cash and cash equivalents at end of period

   $ 38,090     $ 96,337  
    


 


 

 

The accompanying notes are an integral part of these financial statements.

 

5


Table of Contents

ChipPAC, Inc.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Quarter Ended September 30, 2003

(Unaudited)

 

Note 1:    Interim Statements

 

In the opinion of management of ChipPAC, Inc. (“ChipPAC” or the “Company”), the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting solely of normal recurring adjustments) necessary to present fairly the financial information included therein. This financial data should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2002 included in ChipPAC’s 2002 Annual Report on Form 10-K. The accompanying unaudited condensed consolidated financial statements include the accounts of ChipPAC, Inc and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Certain prior period balances have been reclassified to conform to the current period presentation.

 

The results of operations for interim periods are not necessarily indicative of the results of operations that may be expected for any other period or the fiscal year that ends on December 31, 2003. The interim period ended on September 28, 2003, the Sunday nearest September 30th.

 

Recent Accounting Pronouncements

 

In May 2002, the FASB issued SFAS No. 145, “Rescission of SFAS Nos. 4, 44, and 64, Amendment of SFAS No. 13, and Technical Corrections.” Among other things, SFAS No. 145 rescinds various pronouncements regarding early extinguishment of debt and allows extraordinary accounting treatment for early extinguishment only when the provisions of Accounting Principles Board Opinion No. 30, “Reporting the Results of Operations—Reporting the Effects of Disposal of a Segment of a Business and Extraordinary, Unusual and Infrequently Occurring Events and Transactions” are met. SFAS No. 145 provisions regarding early extinguishment of debt are generally effective for fiscal years beginning after May 15, 2002. In the second quarter of 2003, the Company has reclassified a loss on extinguishment of debt that was previously classified as an extraordinary item in prior periods but did not meet the criteria in APB Opinion No. 30 for classification as an extraordinary item and has included it within income from continuing operations.

 

In June 2002, the FASB issued SFAS No. 146, “Accounting for Exit or Disposal Activities.” SFAS No. 146 addresses significant issues regarding the recognition, measurement, and reporting of costs that are associated with exit and disposal activities, including restructuring activities that are currently accounted for under EITF No. 94-3, “Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (Including Certain Costs Incurred in a Restructuring).” The scope of SFAS No. 146 also includes costs related to terminating a contract that is not a capital lease and termination benefits that employees who are involuntarily terminated receive under the terms of a one-time benefit arrangement that is not an ongoing benefit arrangement or an individual deferred-compensation contract. SFAS No. 146 is effective for exit or disposal activities that are initiated after December 31, 2002 and early application is encouraged. The Company adopted SFAS No. 146 during the first quarter of fiscal year 2003. The effect on adoption of SFAS No. 146 changes on a prospective basis the timing of when restructuring charges are recorded from a commitment date approach to when the liability is incurred.

 

In November 2002, the Financial Accounting Standards Board issued FASB Interpretation No. 45, or FIN 45, “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others.” FIN 45 requires that a liability be recorded in the guarantor’s balance sheet upon issuance of a guarantee. In addition, FIN 45 requires disclosures about the guarantees that an entity has issued, including a reconciliation of changes in the entity’s product warranty liabilities. The initial recognition and initial measurement provisions of FIN 45 are applicable on a prospective basis to guarantees issued or modified after December 31, 2002, irrespective of the guarantor’s fiscal year-end. The Company adopted FIN 45 in the first quarter of 2003 and has met the disclosure requirements of FIN 45. The adoption of FIN 45 has no material impact on the Company’s financial statements.

 

In November 2002, the Emerging Issues Task Force, or EITF, reached a consensus on Issue No. 00-21, “Revenue Arrangements with Multiple Deliverables.” EITF Issue No. 00-21 provides guidance on how to account for arrangements that involve the delivery or performance of multiple products, services and/or rights to use assets. The provisions of EITF Issue No. 00-21 will apply to revenue arrangements entered into in fiscal periods beginning after June 15, 2003. The Company has adopted EITF Issue No. 00-21. The adoption of EITF Issue No. 00-21 has no material impact on the Company’s financial statements.

 

In December 2002, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 148, “Accounting for Stock-Based Compensation, Transition and Disclosure.” SFAS No. 148 provides alternative methods of transition for a voluntary change to the fair value based method of accounting for stock-based employee compensation. SFAS No. 148 also requires that disclosures of the pro forma effect of using the fair value method of accounting for stock-based

 

6


Table of Contents

employee compensation be displayed more prominently and in a tabular format. Additionally, SFAS No. 148 requires disclosure of the pro forma effect in interim financial statements. The transition and annual disclosure requirements of SFAS No. 148 are effective for fiscal years ended after December 15, 2002. The interim disclosure requirements are effective for interim periods beginning after December 15, 2002. The Company adopted SFAS No. 148 in the first quarter of 2003. The adoption of SFAS No. 148 has no material impact on its financial statements.

 

In January 2003, the Financial Accounting Standards Board issued FASB Interpretation No. 46, or FIN 46, “Consolidation of Variable Interest Entities, an Interpretation of ARB No. 51.” FIN 46 requires certain variable interest entities to be consolidated by the primary beneficiary of the entity if the equity investors in the entity do not have the characteristics of a controlling financial interest or do not have sufficient equity at risk for the entity to finance its activities without additional subordinated financial support from other parties. FIN 46 is effective immediately for all new variable interest entities created or acquired after January 31, 2003. For variable interest entities created or acquired prior to February 1, 2003, the provisions of FIN 46 must be applied for the first interim or annual period beginning after December 15, 2003. The Company believes that the adoption of this standard will have no material impact on its financial statements.

 

In May 2003, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 150, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity,” SFAS No. 150 establishes standards for how an issuer classifies and measures certain financial instruments with characteristics of both liabilities and equity. SFAS No. 150 requires that an issuer classify a financial instrument that is within its scope as a liability (or an asset in some circumstances). SFAS No. 150 is effective for financial instruments entered into or modified after May 31, 2003, and otherwise is effective at the beginning of the first interim period beginning after June 15, 2003. The Company believes that the adoption of this standard will have no material impact on its financial statements.

 

Stock-Based Compensation

 

The Company has adopted the disclosure only provisions of SFAS No. 123. Accordingly, no compensation expense has been recognized for the Company’s stock option and purchase plan activity as all options granted under those plans had an exercise price equal to the market value of the underlying common stock on the date of grant. If compensation expense had been determined based on the grant date fair value for awards, in accordance with the provisions of SFAS No. 123, the Company’s net loss and loss per share would have been adjusted to the pro forma amounts indicated below:

 

    

Three Months Ended

September 30,


   

Nine Months Ended

September 30,


 
    

(In thousands, except

for per share amounts)

   

(In thousands, except

for per share amounts)

 
     2003

    2002

    2003

    2002

 

Net loss as reported

   $ (17,919 )       $ (3,179 )       $ (32,045 )       $ (21,872 )    

Add: Total stock-based employee compensation included in net loss, net of related tax effects

                        

Deduct: Total stock-based employee compensation expenses determined under fair value method for awards, net of related tax effects

     1,706       1,109       3,490       3,605  
    


 


 


 


Pro forma net loss

   $ (19,625 )   $ (4,288 )   $ (35,535 )   $ (25,477 )
    


 


 


 


Net loss per share as reported:

                                

Basic

   $ (0.19 )   $ (0.03 )   $ (0.34 )   $ (0.26 )

Diluted

   $ (0.19 )   $ (0.03 )   $ (0.34 )   $ (0.26 )

Pro forma net loss per share:

                                

Basic

   $ (0.21 )   $ (0.05 )   $ (0.37 )   $ (0.30 )

Diluted

   $ (0.21 )   $ (0.05 )   $ (0.37 )   $ (0.30 )

Weighted average shares used in per share calculation:

                                

Basic

     95,710       93,421       95,065       85,166  

Diluted

     95,710       93,421       95,065       85,166  

 

The following assumptions were used to determine the pro forma impact of accounting for stock options issued during the three and nine months ended September 30, 2003 and September 30, 2002: (1) risk-free interest rate of 2.9% and 2.5%, respectively, (2) dividend yield of 0.0%, (3) expected life of four years, and (4) volatility of 58.4% and 53.3%, respectively.

 

7


Table of Contents

Note 2:    Selected Balance Sheet Accounts

 

The components of inventories were as follows (in thousands):

 

    

September 30,

2003


  

December 31,

2002


Raw materials

   $ 16,973    $ 11,198

Work in process

     3,696      3,293

Finished goods

     272      808
    

  

     $ 20,941    $ 15,299
    

  

 

Property, plant and equipment were comprised of the following (in thousands):

 

    

September 30,

2003


   

December 31,

2002


 

Land use rights

   $ 11,171     $ 12,368  

Buildings and improvements

     69,218       66,404  

Equipment

     573,624       529,710  
    


 


       654,013       608,482  

Less accumulated depreciation and amortization

     (293,903 )     (272,085 )
    


 


     $ 360,110     $ 336,397  
    


 


 

Other assets were comprised of the following (in thousands):

 

    

September 30,

2003


  

December 31,

2002


Deposits

   $ 1,006    $ 836

Long-term, non-executive, employee loans

     1,017      802

Debt issuance costs, net of amortization of $4,700 and $5,944

     12,765      10,132

Other

     4,125      1,187
    

  

     $ 18,913    $ 12,957
    

  

 

Intangible assets balances are summarized as follows (in thousands):

 

     September 30, 2003

   December 31, 2002

     Gross
Assets


   Accumulated
Amortization


  

Net

Assets


   Gross
Assets


   Accumulated
Amortization


  

Net

Assets


Intellectual property

   $ 16,491    $ 6,715    $ 9,776    $ 15,734    $ 4,980    $ 10,754

Software and software development

     16,187      10,385      5,802      14,231      8,460      5,771

Licenses

     4,497      4,126      371      4,422      3,647      775
    

  

  

  

  

  

     $ 37,175    $ 21,226    $ 15,949    $ 34,387    $ 17,087    $ 17,300
    

  

  

  

  

  

 

Amortization expense for intangible assets is summarized as follows (in thousands):

 

    

Three Months
Ended

September 30,


  

Nine Months
Ended

September 30,


     2003

   2002

   2003

   2002

Intellectual property

   $ 594    $ 535    $ 1,735    $ 1,572

Software and software development

     679      659      1,925      1,947

Licenses

     183      134      479      242
    

  

  

  

     $ 1,456    $ 1,328    $ 4,139    $ 3,761
    

  

  

  

 

 

8


Table of Contents

Intangible assets are being amortized over estimated useful lives of three to seven years. Estimated future amortization expense is as follows (in thousands):

 

October 1, 2003 to December 31, 2003

   $ 1,489

2004

     4,892

2005

     4,341

2006

     3,304

2007

     1,497

Thereafter

     426
    

Total

   $ 15,949
    

 

Accrued expenses and other liabilities were comprised of the following (in thousands):

 

    

September 30,

2003


  

December 31,

2002


Payroll and related items

   $ 14,814    $ 14,778

Interest payable

     5,893      9,210

Other expenses

     5,007      5,412
    

  

     $ 25,714    $ 29,400
    

  

 

In the three month period ended September 30, 2003, ChipPAC’s management approved restructuring plans to realign its organization and reduce operating costs. These actions were designed to better align the Company’s workforce and to reduce operating expenses. These plans were a combination of reductions in work force and employee furloughs. Restructuring charges of $1.9 million were expensed during the three month period ended September 30, 2003. As of September 30, 2003, the Company has reduced its work force by 252 employees. Components of the accrued restructuring costs and amount charged for restructuring as of September 30, 2003 are as follow (in thousands):

 

     Accrual

   Expenditure

   Balance
September 30,
2003


Employee separations

   $ 1,957    $ 1,417    $ 540
    

  

  

 

Note 3:    Line of Credit and Other Bank Borrowings

 

Line of Credit

 

The Company has a borrowing capacity of $50.0 million for working capital and general corporate purposes under the revolving credit line portion of its senior credit facility. The revolving credit line under the senior credit facility matures on July 31, 2005. During the three month period ended September 30, 2003, the Company did not utilize any borrowings against this revolving line of credit and as of September 30, 2003, there was no outstanding balance on the revolving line of credit and the entire $50.0 million was available to the Company.

 

The Company has also established two separate lines of credit with Korean Exchange Bank and Cho Hung Bank, with credit limits of $4.0 million and $8.0 million, respectively. During the three month period ended September 30, 2003, no borrowings were made against either of these lines of credit. Both agreements are subject to an annual review by Korean Exchange Bank and Cho Hung Bank for the continued use of the credit line facility. The Company also has a line of credit available with Southern Bank Bhd. for $0.5 million. During the three month period ended September 30, 2003, the Company borrowed $0.3 million against this line of credit loan for general corporate purposes at the interest rate of 6.9% per annum. As of September 30, 2003, there was no outstanding balance on this credit line.

 

Other Borrowings

 

        On May 28, 2003, the Company issued $125.0 million of 2.5% convertible subordinated notes due 2008 in a private placement and on June 5, 2003, the initial purchaser exercised the option to purchase an additional $25.0 million of 2.5% senior subordinated notes under the same terms. The $150.0 million of 2.5% convertible subordinated notes are convertible into shares of the Company’s Class A common stock at a conversion price of $8.062 per share, subject to adjustment, at any time prior to June 1, 2008, and bear an interest rate of 2.5% per annum. The Company used $63.9 million from the proceeds of these notes to pay down term loans of $36.2 million, a foreign loan of $16.7 million and revolving loans of $11.0 million. The remaining $61.1 million is being used for general corporate purposes. On October 3, 2003, the Company filed a registration statement with the Securities Exchange Commission on Form S-3, which is not yet effective, for these notes along with the shares of common stock into which the notes are convertible.

 

As of September 30, 2003, the Company’s total debt consisted of $365.0 million of borrowings, which was comprised of $165.0 million of 12.75% senior subordinated notes, $50.0 million of 8.0% convertible subordinated notes and $150.0 million of 2.5% convertible subordinated notes.

 

Note 4:    Common Stock Offerings

 

On January 30, 2002, the Company sold 10,000,000 shares of Class A common stock in an underwritten public offering for $6.00 per share. On February 14, 2002, the Company sold an additional 1,425,600 shares of Class A common stock in conjunction with the underwriter’s exercise of their over-allotment option for $6.00 per share. In connection with these sales, the Company received net proceeds of approximately $63.8 million, after deducting underwriting discounts, commissions and

 

9


Table of Contents

estimated offering expenses. Net proceeds of $62.4 million from this offering were used to pay down term loans and revolving loans. The remaining $1.4 million was used for general corporate purposes.

 

On May 30, 2002, the Company sold 12,000,000 shares of Class A common stock in an underwritten public offering for $8.75 per share. In connection with these sales, the Company received net proceeds of approximately $99.2 million, after deducting underwriting discounts, commissions and estimated offering expenses. Net proceeds of $50.0 million from this offering were used to pay down term loans and revolving loans. The remaining $49.2 million was used for general corporate purposes.

 

Sources and Use of Funds From Issuance of Common Stock

 

     January
2002
Offering


   

May

2002
Offering


    Totals

 

Source of funds:

                        

Gross proceeds from issuance of common stock

   $ 68,554     $ 105,000     $ 173,554  

Less: related issuance costs

     (4,768 )     (5,830 )     (10,598 )
    


 


 


Net proceeds from issuance of common stock

   $ 63,786     $ 99,170     $ 162,956  
    


 


 


Use of funds:

                        

Repayment of senior credit facilities

   $ 62,438     $ 50,000     $ 112,438  

General corporate purposes

     1,348       49,170       50,518  
    


 


 


     $ 63,786     $ 99,170     $ 162,956  
    


 


 


 

Note 5:    Acquisition of Malaysian Business

 

On June 30, 2000, the Company consummated the acquisition of Intersil’s packaging and test operations located in Kuala Lumpur, Malaysia, along with related intellectual property for approximately $71.5 million in cash and preferred stock. Additionally, in 2000, $2.4 million of other purchase price adjustments were recorded based on the difference between the final closing balance sheet and the estimated closing balance sheet of the Malaysian business. The terms of the acquisition of the Malaysian business required the Company to pay additional contingent incentive payments to Intersil of approximately $17.9 million based on the achievement of milestones. Cumulatively, as of September 30, 2003, $17.9 million of contingent incentive payments have been made and the Company recorded these contingent payments as additional purchase price. Deferred tax of $5.6 million has been recorded on all of these adjustments, which resulted in a further increase of the effective purchase price and non-current assets.

 

There was no goodwill arising from the acquisition of the Malaysian business. The fair value of total assets and liabilities exceed the purchase price by $56.2 million as of July 1, 2000. This amount, reduced by the additional contingent incentive payments, other purchase price adjustments and related deferred taxes, as of September 30, 2003, has been allocated in full to non-current assets as summarized below:

 

 

Non-current assets


  

Estimated

Fair Value


  

Initial
Excess of Fair

Value of

Acquired Net
Assets Over Cost


   

Total

Additional
Purchase
Price


   Adjusted
Fair Value


     (in millions)

Land and buildings

   $ 27.9    $ (11.1 )   $ 4.9    $ 21.7

Plant and equipment

     93.9      (36.9 )     17.9      74.9

Intellectual property

     20.9      (8.2 )     3.1      15.8
    

  


 

  

     $ 142.7    $ (56.2 )   $ 25.9    $ 112.4
    

  


 

  

 

Note 6:    Earnings Per Share

 

SFAS No. 128 requires a reconciliation of the numerators and denominators of the basic and diluted per share computations. Basic earnings per share (“EPS”) is computed by dividing net income (loss) available to stockholders (numerator) by the weighted average number of shares of common stock outstanding (denominator) during the period. Diluted EPS is computed using the weighted average number of shares of common stock and all potentially dilutive shares of common stock outstanding during the period. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options and the if-converted method is used for determining the number of shares assumed issued from the conversion of the convertible subordinated notes.

 

 

10


Table of Contents

As of September 30, 2003, there were options outstanding to purchase 8.2 million shares of Class A common stock with a weighted average exercise price of $3.74, which could potentially dilute basic EPS in the future, but were not included in diluted EPS as their effect would have been antidilutive due to the net loss. The Company also has outstanding $50.0 million convertible subordinated notes which are convertible into approximately 5.0 million shares of Class A common stock at $9.96 per share and $150.0 million convertible subordinated notes which are convertible into approximately 18.6 million shares of Class A common stock at $8.062 per share. These were not included in diluted EPS as their effect would also have been antidilutive due to the net loss. The following is a reconciliation of the numerators and denominators of the basic and diluted EPS computations for the periods presented below.

 

 

    

Three Months Ended

September 30, 2003


    

Three Months Ended

September 30, 2002


 
    

Net

Loss


    

Shares


  

Per-Share

Amount


    

Net

Loss


    

Shares


  

Per-Share

Amount


 
     (In thousands, except per share amounts)  

Basic EPS:

                                             

Net loss per share

   $ (17,919 )    95,710    $ (0.19 )    $ (3,179 )    93,421    $ (0.03 )

Diluted EPS:

                                             

Net loss per share

   $ (17,919 )    95,710    $ (0.19 )    $ (3,179 )    93,421    $ (0.03 )
    

Nine Months Ended

September 30, 2003


    

Nine Months Ended

September 30, 2002


 
    

Net

Loss


    

Shares


  

Per-Share

Amount


    

Net

Loss


    

Shares


  

Per-Share

Amount


 

Basic EPS:

                                             

Net loss per share

   $ (32,045 )    95,065    $ (0.34 )    $ (21,872 )    85,166    $ (0.26 )

Diluted EPS:

                                             

Net loss per share

   $ (32,045 )    95,065    $ (0.34 )    $ (21,872 )    85,166    $ (0.26 )

 

Note 7:    Contingent Liabilities

 

During the quarter ended June 30, 2002, an assessment of approximately 16.0 billion Korean Won (approximately $13.9 million U.S. Dollars at September 30, 2003) was made by the Korean National Tax Administration, or NTA, relating to withholding tax not collected on the loan between the Company’s subsidiaries in Korea and Hungary. The prevailing tax treaty does not require withholding on the transactions in question. There were no further assessments made during the quarter ended September 30, 2003. The Company has appealed the assessment through the NTA’s Mutual Agreement Procedure and believes that the assessment will be overturned. As of September 30, 2003, no accrual has been made. On July 18, 2002, the Icheon tax office of the NTA approved a suspension of the proposed assessment until resolution of the disputed assessment. The NTA required a corporate guarantee of 120% of the assessment in exchange for the suspension. The Company complied with the guarantee request on August 1, 2002. No further assessments have been made.

 

Note 8:    Acquisition of Cirrus Logic Test Assets

 

On June 30, 2003, the Company acquired the semiconductor test operation assets of Cirrus Logic, Inc. Pursuant to the Asset Purchase Agreement by and between the Company and Cirrus Logic, the Company has paid Cirrus Logic, Inc., $3.5 million in cash. The terms of the acquisition of the Cirrus Logic semiconductor test operation assets also required the Company to pay until June 30, 2007 additional contingent incentive payments to Cirrus Logic, Inc. based on the achievement of milestones with respect to the transfer of the seller’s test business.

 

Note 9:    Sale of Building

 

The Company sold an unutilized building and land, located in its Malaysian facility to Texas Instruments Malaysia for total consideration of $5.5 million. The Company realized a gain of $3.9 million before taxes as a result of the sale.

 

11


Table of Contents

Note 10:    Supplemental Financial Statements of Guarantor/Non-Guarantor Entities

 

In connection with the recapitalization, in August 1999, ChipPAC International Company Limited, (“CP Int’l”), issued senior subordinated debt securities which are fully and unconditionally guaranteed, jointly and severally, on a senior subordinated basis, by the parent company, ChipPAC, Inc. (“CPI”) and by ChipPAC (Barbados) Ltd., ChipPAC Limited, ChipPAC Korea Company Limited (“CPK”), ChipPAC Malaysia Sdn. Bhd. (“CPM”), ChipPAC Luxembourg S.a.R.L., and ChipPAC Liquidity Management Hungary Limited Liability Company (the “Guarantor Subsidiaries”). All Guarantor Subsidiaries are wholly owned direct or indirect subsidiaries of CPI. ChipPAC Shanghai Limited (“CPS”) did not provide guarantees (the “Non-Guarantor Subsidiary”). The following is consolidated financial information for CP Int’l, CPI, CPM, and CPK, CPS, ChipPAC (Barbados) Ltd., ChipPAC Limited, ChipPAC Luxembourg S.a.R.L., and ChipPAC Liquidity Management Hungary Limited Liability Company, segregated between the Guarantor and Non-Guarantor Subsidiaries.

 

 

 

12


Table of Contents

ChipPAC, Inc.

SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEETS

September 30, 2003

(In thousands)

(Unaudited)

 

     Parent
Guarantor
CPI


    Issuer CP
Int’l


    Other
Guarantors


   

Non-

Guarantor
China


    Eliminations

    Consolidated

 
ASSETS                                                 

Current assets:

                                                

Cash and cash equivalents

   $ 13,597     $ 323     $ 22,128     $ 2,042     $     $ 38,090  

Short-term investments

     37,522             5,500                   43,022  

Intercompany accounts receivable

     173,421       20,036       21,675       16,154       (231,286 )      

Accounts receivable, net

                 44,859       32             44,891  

Inventories

                 17,097       3,844             20,941  

Prepaid expenses and other current assets

     1,428             6,727       945             9,100  
    


 


 


 


 


 


Total current assets

     225,968       20,359       117,986       23,017       (231,286 )     156,044  

Property, plant and equipment, net

     5,098       11,645       245,005       98,362             360,110  

Intercompany loans receivable

           202,380                   (202,380 )      

Investment in subsidiaries

     59,043             87,233             (146,276 )      

Intangible assets, net

     808             14,715       426             15,949  

Other assets

     7,655       5,303       5,949       6             18,913  
    


 


 


 


 


 


Total assets

   $ 298,572     $ 239,687     $ 470,888     $ 121,811     $ (579,942 )   $ 551,016  
    


 


 


 


 


 


LIABILITIES AND STOCKHOLDERS’ EQUITY                                                 

Current liabilities:

                                                

Intercompany accounts payable

   $ 156     $ 4,043     $ 204,112     $ 22,975     $ (231,286 )   $  

Accounts payable

     1,965       32       38,729       8,184             48,910  

Accrued expenses and other current liabilities

     6,587       3,638       10,318       5,171             25,714  
    


 


 


 


 


 


Total current liabilities

     8,708       7,713       253,159       36,330       (231,286 )     74,624  

Long-term debt

           165,000                         165,000  

Convertible subordinated notes

     200,000                               200,000  

Intercompany loans payable

                 202,380             (202,380 )      

Other long-term liabilities

                 21,528                   21,528  
    


 


 


 


 


 


Total liabilities

     208,708       172,713       477,067       36,330       (433,666 )     461,152  
    


 


 


 


 


 


Stockholders’ equity:

                                                

Common stock

     966                               966  

Additional paid in capital

     283,017       81,689       174,691       149,093       (405,473 )     283,017  

Receivables from stockholders

     (241 )                             (241 )

Accumulated other comprehensive income

     9,169             8,705       464       (9,169 )     9,169  

Accumulated deficit

     (203,047 )     (14,715 )     (189,575 )     (64,076 )     268,366       (203,047 )
    


 


 


 


 


 


Total stockholders’ equity

     89,864       66,974       (6,179 )     85,481       (146,276 )     89,864  
    


 


 


 


 


 


Total liabilities and stockholders’ equity

   $ 298,572     $ 239,687     $ 470,888     $ 121,811     $ (579,942 )   $ 551,016  
    


 


 


 


 


 


 

13


Table of Contents

ChipPAC, Inc.

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS

Nine Months Ended September 30, 2003

(In thousands)

(Unaudited)

 

     Parent
Guarantor
CPI


    Issuer CP
Int’l


    Other
Guarantors


   

Non-

Guarantor
China


    Eliminations

    Consolidated

 

Intercompany revenue

   $ 19,635     $ 1,368     $     $ 53,409     $ (74,412 )   $  

Customer revenue

                 300,754       78             300,832  
    


 


 


 


 


 


       19,635       1,368       300,754       53,487       (74,412 )     300,832  

Cost of revenue

     425       836       284,529       49,791       (74,412 )     261,169  
    


 


 


 


 


 


Gross profit

     19,210       532       16,225       3,696             39,663  
    


 


 


 


 


 


Operating expenses:

                                                

Selling, general and administrative

     15,762       218       9,645       2,619             28,244  

Research and development

     2,274             6,186       229             8,689  

Restructuring and write-down of impaired assets

     540             9,049       4,030             13,619  
    


 


 


 


 


 


Total operating expenses

     18,576       218       24,880       6,878             50,552  
    


 


 


 


 


 


Operating income (loss)

     634       314       (8,655 )     (3,182 )           (10,889 )

Non-operating (income) expenses

                                                

Inter-company interest expense

                 12,163       1,515       (13,678 )      

Interest expense

     4,819       17,680       305                   22,804  

Interest income

     (445 )           (147 )     (4 )           (596 )

Inter-company interest income

           (13,678 )                 13,678        

(Income) loss from investment in subsidiaries

     28,220             4,593             (32,813 )      

Foreign currency loss

     (1 )           490       30             519  

Gain on sale of building

                 (3,929 )                 (3,929 )

Loss from early debt extinguishment

           1,099       83                   1,182  

Other (income) expenses, net

     81             (275 )     (130 )           (324 )
    


 


 


 


 


 


Total non-operating (income) expense

     32,674       5,101       13,283       1,411       (32,813 )     19,656  
    


 


 


 


 


 


Income / (loss) before income taxes

     (32,040 )     (4,787 )     (21,938 )     (4,593 )     32,813       (30,545 )

Provision for income taxes

     5       276       1,219                   1,500  
    


 


 


 


 


 


Net income / (loss)

   $ (32,045 )   $ (5,063 )   $ (23,157 )   $ (4,593 )   $ 32,813     $ (32,045 )
    


 


 


 


 


 


 

14


Table of Contents

ChipPAC, Inc.

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

Nine Months Ended September 30, 2003

(In thousands)

(Unaudited)

 

     Parent
Guarantor
CPI


    Issuer CP
Int’l


    Other
Guarantors


   

Non-

Guarantor
China


    Eliminations

    Consolidated

 

Cash flows from operating activities:

                                                

Net income (loss)

   $ (32,045 )   $ (5,063 )   $ (23,157 )   $ (4,593 )   $ 32,813     $ (32,045 )

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

                                                

Depreciation and amortization

     761       836       37,893       11,389             50,879  

Amortization of debt issuance cost

     588       996                         1,584  

Foreign currency loss

     (1 )           490       30             519  

Write-off of impaired assets

                 7,632       4,030             11,662  

Loss from early debt extinguishment

           1,099       83                   1,182  

Gain on sale of building

                 (3,929 )                 (3,929 )

Gain on sale of equipment

     (5 )           (288 )     (78 )           (371 )

Equity income (loss) from investment in subsidiaries

     28,220             4,593             (32,813 )      

Changes in assets and liabilities:

                                                

Intercompany accounts receivable

     (57,247 )     48,974       1,490       709       6,074        

Accounts receivable

     17             (6,098 )     (17 )           (6,098 )

Inventories

                 (5,002 )     (640 )           (5,642 )

Prepaid expenses and other current assets

     (459 )           (3,959 )     520             (3,898 )

Other assets

     (78 )           (3,246 )     4             (3,320 )

Intercompany accounts payable

     (803 )     (56,178 )     64,134       (1,079 )     (6,074 )      

Accounts payable

     591       (1,921 )     12,001       (1,516 )           9,155  

Accrued expenses and other current liabilities

     1,310       (5,620 )     1,710       (1,086 )           (3,686 )

Other long-term liabilities

     2             1,852       (30 )           1,824  
    


 


 


 


 


 


Net cash provided by (used in) operating activities

     (59,149 )     (16,877 )     86,199       7,643             17,816  
    


 


 


 


 


 


Cash flows from investing activities:

                                                

Purchases of short-term investments

     (149,118 )           (5,500 )                 (154,618 )

Proceeds from sale of short-term investments

     121,596                               121,596  

Acquisition of property and equipment

     38       (6,899 )     (57,736 )     (11,063 )           (75,660 )

Acquisition of intangible assets

     (474 )           (1,805 )                 (2,279 )

Proceeds from sale of building

                 5,399                   5,399  

Proceeds from sale of equipment

     5             372       102             479  

Acquisition of test assets

                 (3,500 )                 (3,500 )

Malaysian acquisition, net of cash and cash equivalent acquired

                 (3,475 )                 (3,475 )

Investment in subsidiaries

     (54,000 )           (34,000 )           88,000        
    


 


 


 


 


 


Net cash used in investing activities

     (81,953 )     (6,899 )     (100,245 )     (10,961 )     88,000       (112,058 )
    


 


 


 


 


 


Cash flows from financing activities:

                                                

Proceeds from revolving loan and other lines of credit

           26,500       1,204                   27,704  

Repayment of revolving loan and other lines of credit

           (26,500 )     (1,204 )                 (27,704 )

Debt issuance costs

     (180 )                             (180 )

Net proceeds from long-term debt

     144,861                               144,861  

Repayment of long-term debts

           (36,187 )     (16,700 )                 (52,887 )

Intercompany loan payments

           50,120       (16,120 )     (34,000 )            

Intercompany capital contributions

                 54,000       34,000       (88,000 )      

Repayment of notes from stockholders

     239                               239  

Proceeds from common stock issuance

     6,126                               6,126  
    


 


 


 


 


 


Net cash provided by financing activities

     151,046       13,933       21,180             (88,000 )     98,159  
    


 


 


 


 


 


Net increase (decrease) in cash

     9,944       (9,843 )     7,134       (3,318 )           3,917  

Cash and cash equivalents at beginning of period

     3,653       10,166       14,994       5,360             34,173  
    


 


 


 


 


 


Cash and cash equivalents at end of period

   $ 13,597     $ 323     $ 22,128     $ 2,042     $     $ 38,090  
    


 


 


 


 


 


 

 

15


Table of Contents

ChipPAC, Inc.

SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEETS

December 31, 2002

(In thousands)

(Unaudited)

 

     Parent
Guarantor
CPI


    Issuer CP
Int’l


    Other
Guarantors


   

Non-

Guarantor
China


    Eliminations

    Consolidated

 
ASSETS                                                 

Current assets:

                                                

Cash and cash equivalents

   $ 3,653     $ 10,166     $ 14,994     $ 5,360     $     $ 34,173  

Short-term investments

     10,000                               10,000  

Intercompany accounts receivable

     116,175       69,010       23,165       16,863       (225,213 )      

Accounts receivable, net

     17             38,760       16             38,793  

Inventories

                 12,095       3,204             15,299  

Prepaid expenses and other current assets

     968             2,852       1,465             5,285  
    


 


 


 


 


 


Total current assets

     130,813       79,176       91,866       26,908       (225,213 )     103,550  

Property, plant and equipment, net

     5,528       5,582       222,698       102,589             336,397  

Intercompany loans receivable

           252,500                   (252,500 )      

Investment in subsidiaries

     33,263             57,827             (91,090 )      

Intangible assets, net

     703             16,018       579             17,300  

Other assets

     2,847       7,398       2,702       10             12,957  
    


 


 


 


 


 


Total assets

   $ 173,154     $ 344,656     $ 391,111     $ 130,086     $ (568,803 )   $ 470,204  
    


 


 


 


 


 


LIABILITIES AND STOCKHOLDERS’

EQUITY (DEFICIT)

                                                

Current liabilities:

                                                

Intercompany accounts payable

   $ 960     $ 60,221     $ 139,978     $ 24,054     $ (225,213 )   $  

Accounts payable

     1,373       1,953       26,729       9,700             39,755  

Accrued expenses and other current liabilities

     5,277       9,258       8,607       6,258             29,400  
    


 


 


 


 


 


Total current liabilities

     7,610       71,432       175,314       40,012       (225,213 )     69,155  

Long-term debt, less current portion

           201,187       16,700                   217,887  

Convertible subordinated notes

     50,000                               50,000  

Intercompany loans payable

                 218,500       34,000       (252,500 )      

Other long-term liabilities

                 17,618                   17,618  
    


 


 


 


 


 


Total liabilities

     57,610       272,619       428,132       74,012       (477,713 )     354,660  
    


 


 


 


 


 


Stockholders’ equity (deficit):

                                                

Common stock

     941                               941  

Additional paid in capital

     276,916       81,689       120,692       115,093       (317,474 )     276,916  

Receivables from stockholders

     (480 )                             (480 )

Accumulated other comprehensive income

     9,169             8,705       464       (9,169 )     9,169  

Accumulated deficit

     (171,002 )     (9,652 )     (166,418 )     (59,483 )     235,553       (171,002 )
    


 


 


 


 


 


Total stockholders’ equity (deficit)

     115,544       72,037       (37,021 )     56,074       (91,090 )     115,544  
    


 


 


 


 


 


Total liabilities and stockholders’ equity (deficit)

   $ 173,154     $ 344,656     $ 391,111     $ 130,086     $ (568,803 )   $ 470,204  
    


 


 


 


 


 


 

 

16


Table of Contents

ChipPAC, Inc.

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS

Nine Months Ended September 30, 2002

(In thousands)

(Unaudited)

 

     Parent
Guarantor
CPI


    Issuer CP
Int’l


    Other
Guarantors


   

Non-

Guarantor
China


    Eliminations

    Consolidated

 

Intercompany revenue

   $ 21,067     $ 200     $     $ 51,080     $ (72,347 )   $  

Customer revenue

                 270,703       255             270,958  
    


 


 


 


 


 


       21,067       200       270,703       51,335       (72,347 )     270,958  

Cost of revenue

           120       253,259       46,647       (72,347 )     227,679  
    


 


 


 


 


 


Gross profit

     21,067       80       17,444       4,688             43,279  

Operating expenses:

                                                

Selling, general and administrative

     17,613       233       8,261       2,875             28,982  

Research and development

     1,957             5,301                   7,258  
    


 


 


 


 


 


Total operating expenses

     19,570       233       13,562       2,875             36,240  
    


 


 


 


 


 


Operating income (loss)

     1,497       (153 )     3,882       1,813             7,039  

Non-operating (income) expenses

                                                

Inter-company interest expense

                 21,254       2,510       (23,764 )      

Interest expense

     3,300       20,724       455                   24,479  

Interest income

     (291 )     (22 )     (123 )     (19 )           (455 )

Inter-company interest income

           (23,677 )     (87 )           23,764        

Loss from investment in

                                                

    subsidiaries

     20,362             809             (21,171 )      

Foreign currency loss

                 815       45             860  

Loss from early debt extinguishment

           3,005                         3,005  

Other expenses, net

     (5 )           (284 )     (189 )           (478 )
    


 


 


 


 


 


Total non-operating expenses

     23,366       30       22,839       2,347       (21,171 )     27,411  
    


 


 


 


 


 


Loss before income taxes

     (21,869 )     (183 )     (18,957 )     (534 )     21,171       (20,372 )

Provision for income taxes

     3       122       1,100       275             1,500  
    


 


 


 


 


 


Net loss

   $ (21,872 )   $ (305 )   $ (20,057 )   $ (809 )   $ 21,171     $ (21,872 )
    


 


 


 


 


 


 

 

17


Table of Contents

ChipPAC, Inc.

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

Nine Months Ended September 30, 2002

(In thousands)

(Unaudited)

 

     Parent
Guarantor
CPI


    Issuer CP
Int’l


    Other
Guarantors


   

Non-

Guarantor
China


    Eliminations

    Consolidated

 

Cash flows from operating activities:

                                                

Net loss

   $ (21,872 )   $ (305 )   $ (20,057 )   $ (809 )   $ 21,171     $ (21,872 )

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

                                                

Depreciation and amortization

     1,170       120       31,827       9,830             42,947  

Amortization of debt issuance cost

     140       1,692                         1,832  

Foreign currency (gains) loss

                 815       45             860  

Loss from early debt extinguishment

           3,005                         3,005  

(Gain) loss on sale of equipment

                 (78 )     13             (65 )

Equity income from investment in subsidiaries

     20,362             809             (21,171 )      

Changes in assets and liabilities:

                                                

Intercompany accounts receivable

     (144,546 )     13,682       (1,422 )     (7,671 )     139,957        

Accounts receivable

     13       9       (5,838 )     (33 )           (5,849 )

Inventories

                 (2,604 )     (948 )           (3,552 )

Prepaid expenses and other current assets

     (535 )     (38 )     (435 )     (579 )           (1,587 )

Other assets

     367       (65 )     (4,573 )     (586 )           (4,857 )

Intercompany accounts payable

     510       110,072       26,975       2,400       (139,957 )      

Accounts payable

     (109 )     (691 )     3,041       1,780             4,021  

Accrued expenses and other current liabilities

     3,203       (7,351 )     2,873       1,248             (27 )

Other long-term liabilities

                 4,796                   4,796  
    


 


 


 


 


 


Net cash provided by (used in) operating activities

     (141,297 )     120,130       36,129       4,690             19,652  
    


 


 


 


 


 


Cash flows from investing activities:

                                                

Acquisition of property, plant and equipment

     (66 )     (3,837 )     (41,920 )     (12,176 )           (57,999 )

Acquisition of intangible assets

     (462 )           (2,015 )     (67 )           (2,544 )

Proceeds from sale of equipment

                 86                   86  

Malaysian acquisition, net of cash and cash equivalents acquired

                 (5,873 )                 (5,873 )

Investment in subsidiaries

                 (7,507 )           7,507        
    


 


 


 


 


 


Net cash used in investing activities

     (528 )     (3,837 )     (57,229 )     (12,243 )     7,507       (66,330 )
    


 


 


 


 


 


Cash flows from financing activities:

                                                

Proceeds from revolving loan and other lines of credit

           100,000       5,596                   105,596  

Repayment of revolving loan

           (100,000 )     (5,596 )                 (105,596 )

Increase in debt issuance costs

           (703 )                       (703 )

Net proceeds from long-term debt

           (82,440 )     16,700                   (65,740 )

Repayment of notes from stockholders

     505                               505  

Intercompany loan payments

                       7,507       (7,507 )      

Proceeds from common stock issuance

     167,105                               167,105  

Repurchase of common stock

     (24 )                             (24 )
    


 


 


 


 


 


Net cash provided by (used in) financing activities

     167,586       (83,143 )     16,700       7,507       (7,507 )     101,143  
    


 


 


 


 


 


Net increase (decrease) in cash

     25,761       33,150       (4,400 )     (46 )           54,465  

Cash and cash equivalents at beginning of period

     1,842       17,093       20,939       1,998             41,872  
    


 


 


 


 


 


Cash and cash equivalents at end of period

   $ 27,603     $ 50,243     $ 16,539     $ 1,952     $     $ 96,337  
    


 


 


 


 


 


 

18


Table of Contents
ITEM 2.   MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

All references are to ChipPAC’s fiscal quarters ended September 30, 2003 and September 30, 2002, unless otherwise indicated. This quarterly report on Form 10-Q contains forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “plan,” “target,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and speak only as of their dates. These forward-looking statements are based on our current expectations and are subject to a number of risks and uncertainties, including those identified under Exhibit 99.1 filed with our annual report on Form 10-K for the year ended December 31, 2002 and other risks and uncertainties indicated from time to time in our filings with the SEC. Actual results could differ materially from these forward-looking statements. In addition, important factors to consider in evaluating these forward-looking statements include changes in external market factors, changes in our business or growth strategy or an inability to execute our strategy due to changes in our industry or the economy generally, the emergence of new or growing competitors and various other competitive factors. Also, terrorist acts, war, political unrest or disease epidemics in the regions where we have operations could materially affect our financial condition and our results of operation. In light of these risks and uncertainties, there can be no assurance that the matters referred to in the forward-looking statements contained in this quarterly report will in fact occur.

 

Results of Operations

 

Three and nine month periods ended September 30, 2003 compared to three and nine month periods ended September 30, 2002

 

Revenue.    Revenue was $105.4 million and $300.8 million for the three and nine month periods ended September 30, 2003, respectively, an increase of 11.4% and 11.0% compared to revenue of $94.7 million and $271.0 million for the same periods in 2002, respectively. New customers were added in the latter half of 2002 and these new customers have been increasing production since the beginning of the year. In addition, we have expanded our products and services to our existing customer base in 2003. These factors contributed to the increase of revenue over the same periods in 2002. We expect that demand and revenue will continue to improve. Assembly unit volumes for the three and nine month periods ended September 30, 2003, increased 12.2% and 9.6%, respectively, over the same periods in 2002. Average selling prices per pin for the three and nine month periods ended September 30, 2003, decreased 10.4% and 5.4%, respectively, compared to the same periods in 2002.

 

Gross Profit.    Gross profit during the three and nine month periods ended September 30, 2003 was $13.0 million and $39.7 million, a decrease of 18.8% and 8.4% compared to gross profit of $16.0 million and $43.3 million for the same periods in 2002, respectively. Gross margin as a percent of revenue was 12.4% and 13.2% for the three and nine month periods ended September 30, 2003, as compared to 16.9% and 16.0% in the same period in 2002, respectively. For the three and nine month periods ended September 30, 2003 compared to the same period in 2002, gross profit percentage declined due to substrate pricing increases, lower margin products making up a larger weighted factor in our overall product mix, rising costs of materials in reaction to macroeconomic issues including South Korean exchange rate valuations and increased gold market prices and non-recurring expenses of $0.6 million related to inventory write downs and facility moving expenses. Overall equipment utilization was approximately 60.2 % for the three month period ended September 30, 2003 as compared to 63.0 % in the same period in 2002. We expect gross profit to improve as a result of our restructuring.

 

Selling, General, and Administrative.    Selling, general and administrative expenses were $10.3 million and $28.2 million for the three and nine month periods ended September 30, 2003 as compared to $9.4 million and $29.0 million for the same periods in 2002. Selling, general and administrative expenses increased 10.2% for the three month period ended September 30, 2003 as compared to the same period in 2002. For the nine month period ended September 30, 2003, selling, general and administrative expenses decreased 2.5% compared to the same period in 2002. As a percentage of revenue, selling, general and administrative expenses were 9.8% and 9.4% for the three and nine month periods ended September 30, 2003, respectively, compared to 9.9% and 10.7% for the same periods in 2002, respectively. During the three month period ended September 30, 2003, expenses increased primarily from activities related to selling expenses. The decrease in expenses as a percentage of revenue for the nine month period for September 30, 2003 expenses compared to the 2002 periods was due to cost and hiring controls keeping spending under the percentage increase in revenue.

 

Research and Development.    Research and development expenses for the three and nine month periods ended September 30, 2003 were $2.7 million and $8.7 million, respectively, versus $2.6 million and $7.3 million for the same periods in 2002, an increase of 7.0% and 19.7% from the three and nine month periods ended September 30, 2002, respectively. Throughout 2003, we have continued to increase our research and development staffing and projects at all three of our plants. The increased staffing and increased number of projects in 2003 drove the additional spending compared to the same periods in 2002.

 

 

19


Table of Contents

Restructuring Charge and Write Down of Impaired Assets.    During the three month period ended September 30, 2003, restructuring plans were executed to realign our organization and reduce operating costs to better align our expenses with revenues. As of September 30, 2003, we had a total reduction of 252 personnel related to the restructuring. Restructuring and related charges of $1.9 million were expensed during the three month period ended September 30, 2003.

 

In addition, during the three month period ended September 30, 2003, we wrote down impaired assets by $11.7 million. We determined that the expected cash flows related to certain manufacturing equipment was not sufficient to recover the carrying value of the equipment. As the result of this, the carrying values of these assets were written down to the estimated fair market value and will continue to be depreciated over the remaining useful lives. There were no equivalent write-offs in the same period during 2002.

 

Interest Expense.    Total outstanding interest-bearing debt was $365.0 million at September 30, 2003 versus $317.9 million at September 30, 2002. The increase in debt outstanding of $47.1 million from September 30, 2002 to September 30, 2003, is attributable to the issuance of $150.0 million convertible debt in May 2003 offset by the pay down of $102.9 million of term loans and other lines of credits and revolver loans. Related interest expense was $7.9 million and $22.8 million for the three and nine month periods ended September 30, 2003, an increase of 2.9% as compared to $7.7 million for the three month period and a decrease of 6.8% as compared to $24.5 million for the nine month period ended September 30, 2002. Despite the increase in total outstanding debt at September 30, 2003 as compared to September 30, 2002, interest expense decreased primarily as the result of lower interest rates on the new convertible debt that replaced debt with significantly higher rates. Total interest expenses paid in cash for the nine months ended September 30, 2003 were $24.8 million.

 

Foreign Currency Losses.    Net foreign currency losses were $0.3 million and $0.5 million for the three and nine month periods ended September 30, 2003, respectively, as compared to a net foreign currency gain of $0.5 million for the same three month period in 2002 and a net foreign currency loss of $0.9 million for the same nine month period in 2002. These non-cash losses were primarily due to the fluctuations between the exchange rate of the United States Dollar and the South Korean Won related to long-term severance benefits payable to our South Korean employees in Korean Won.

 

Loss From Early Extinguishment of Debt.    In May and June 2003, we issued $150.0 million of 2.5% convertible subordinated notes in a private placement and used a portion of the proceeds to payoff term loans and foreign debt. As a result of the early extinguishment of these loans and debt, associated capitalized debt issuance cost of $1.2 million In May 2002, we used proceeds from our secondary public offering to pay off term loans. As the result of this early extinguishment of debt, associated capitalized debt issuance cost of $3.0 million were written-off. There were no additional related expenses in the three month period ended September 30, 2003.

 

Income Taxes.    Consolidated income tax provisions were $0.5 million and $1.5 million for both of the three and nine month periods ended September 30, 2003 and 2002, respectively. We have a mix of tax rates across the various jurisdictions in which we do business, and our current estimated provision for 2003 is $2.0 million with $0.5 million recognized in the three month period ended September 30, 2003. This estimate does not take into account any future benefit from loss carryforwards, which we may realize once we again achieve profitability and begin generating taxable income.

 

Critical Accounting Policies

 

For critical accounting policies affecting us, see Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended December 31, 2002. Critical accounting policies affecting us have not changed materially since December 31, 2002.

 

Liquidity and Capital Resources

 

Our ongoing primary cash needs are for operations and equipment purchases. We spent $30.9 million and $75.7 million on capital expenditures during the three and nine month periods ended September 30, 2003, respectively, as compared to $18.1 million and $58.0 million in capital expenditures during the same periods in 2002, respectively. In addition, $3.5 million was invested for the Cirrus Logic’s back-end wafer probe and test assets.

 

As of September 30, 2003, our total debt consisted of $365.0 million of borrowings, which was comprised of $165.0 million of 12.75% senior subordinated notes, $50.0 million of 8.0% convertible subordinated notes and $150.0 million of 2.5% convertible subordinated notes.

 

20


Table of Contents

Our senior credit facilities, as amended, contain covenants restricting our operations and requiring that we meet specified financial tests. The financial covenants consist solely of a minimum interest coverage ratio and a maximum senior leverage ratio based on a rolling 12-months calculation. There were no violations of the covenants under the senior credit facilities, as amended, through September 30, 2003.

 

Other than the covenants on the debt as discussed above and the tax guarantee to the Korean Tax Authorities and discussed below, we have no performance guarantees. We also have no investment in any unconsolidated entities. Our off-balance sheet commitments are limited to equipment operating leases, royalty/license agreements, and leases on office and manufacturing space. Our total off-balance sheet obligations are approximately $56.2 million as of September 30, 2003.

 

Our total commitments on our loans, operating leases, and other agreements as of September 30, 2003, were as follows (in thousands):

 

     Total

   Within
1 Year


   2–3
Years


   4–5 Years

   After 5
Years


On balance sheet commitments:

                                  

Senior subordinated notes

   $ 165,000    $    $    $    $ 165,000

Convertible subordinated notes

     200,000                150,000      50,000
    

  

  

  

  

Total on balance sheet commitments

     365,000                150,000      215,000
    

  

  

  

  

Off balance sheet commitments:

                                  

Operating leases

     55,009      2,361      12,757      10,782      29,109

Royalty/licensing agreements

     1,148      66      802      280     
    

  

  

  

  

Total off balance sheet commitments

     56,157      2,427      13,559      11,062      29,109
    

  

  

  

  

Total commitments

   $ 421,157    $ 2,427    $ 13,559    $ 161,062    $ 244,109
    

  

  

  

  

 

During the quarter ended June 30, 2002, an assessment of approximately 16.0 billion Korean Won (approximately $13.9 million U.S. Dollars at September 30, 2003), was made by the Korean National Tax Administration, or NTA, relating to withholding tax not collected on the loan between our subsidiaries in Korea and Hungary. The prevailing tax treaty does not require withholding on the transactions in question. There were no further assessments made during the quarter ended September 30, 2003. We have appealed the assessment through the NTA’s Mutual Agreement Procedure and believe that the assessment will be overturned. As of September 30, 2003, no accrual has been made. On July 18, 2002, the Icheon tax office of the NTA approved a tax suspension of the proposed assessment until resolution of the disputed assessment. The NTA required a corporate guarantee of 120% of the assessment in exchange for the suspension. We complied with the guarantee request on August 1, 2002. No further assessments have been made.

 

For the nine month periods ended September 30, 2003 and 2002, cash provided by operations was $17.8 million and $19.7 million, respectively. Cash provided by operations is calculated by adjusting our net loss by non-cash related items such as depreciation and amortization, debt issuance cost amortization, write down of impaired assets, gains from sale of assets, loss from early extinguishment of debt and foreign currency loss and by changes in assets and liabilities. During the nine month period ended September 30, 2003, non-cash related items included $50.9 million related to depreciation and amortization, $1.6 million from debt issuance costs, $11.7 million from write down of impaired assets, $4.3 million from gain on sale of assets, $1.2 million loss from early extinguishment of debt and $0.5 million from foreign currency loss. Working capital uses of cash included increases in accounts receivable, inventories, prepaid assets, and a decrease in accrued liabilities, primarily due to interest payments made. Working capital sources of cash primarily was due to an increase in accounts payable.

 

For the nine month period ended September 30, 2003, cash used in investing activities was $112.1 million versus $66.3 million for the same period in 2002. During the nine month period ended September 30, 2003, $75.7 million was used for capital expenditures and $3.5 million was invested in Cirrus Logic’s back-end wafer probe and test assets. In addition, the final $3.5 million was invested in the purchase of the Malaysian business, including purchased intellectual property. Proceeds from sale of assets were $5.9 million, which includes $5.5 million related to the sale of our building in Malaysia.

 

For the nine month period ended September 30, 2003, cash provided by financing activities was $98.2 million as compared to $101.1 million for the same period in 2002. In May and June 2003, $144.9 million, after deducting transaction costs, was provided by the issuance of subordinated convertible notes in a private placement. As of September 30, 2003, there were no outstanding borrowing on the revolving loan and the line of credit facilities. During the nine month period ended September 30, 2003, $6.1 million was provided by the issuance of new common stock through the employee stock purchase plan and employee stock option plans.

 

21


Table of Contents

The terms of the acquisition of the Malaysian business required contingent incentive payments to Intersil, up to a maximum of $17.9 million through June 30, 2003. There were no additional accruals related to the acquisition in the three month period ended September 30, 2003. Cumulatively we have paid $17.9 million under this arrangement, which completed our required payments.

 

On January 30, 2002, we sold 10,000,000 shares of Class A common stock in an underwritten public offering for $6.00 per share. On February 14, 2002, we sold an additional 1,425,600 shares of Class A common stock in conjunction with the underwriter’s exercise of their over-allotment option at the public offering price for $6.00 per share. In connection with these sales, we received net proceeds of approximately $63.8 million, after deducting underwriting discounts, commissions and offering expenses. Net proceeds of $62.4 million from this offering were used to pay down term loans and revolving loans. The remaining $1.4 million was used for general corporate purposes.

 

On May 30, 2002, we sold 12,000,000 shares of Class A common stock in an underwritten public offering for $8.75 per share. In connection with this sale, we received net proceeds of approximately $99.2 million, after deducting underwriting discounts, commissions and offering expenses. Net proceeds of $50.0 million from this offering were used to pay down term loans. The remaining $49.2 million was used for general corporate purposes.

 

On May 28, 2003, we issued $125.0 million of 2.5% convertible subordinated notes due 2008 in a private placement and on June 5, 2003, the initial purchaser exercised the option to purchase an additional $25.0 million of 2.5% convertible subordinated notes under the same terms. The $150.0 million of 2.5% convertible subordinated notes are convertible into shares of our Class A common stock at a conversion price of $8.062 per share, subject to adjustment at any time prior to June 1, 2008 and bear an interest rate of 2.5% per annum. We used $63.9 million from the proceeds of these notes to pay down $36.2 million of our term loans, $16.7 million of foreign loan of and $11.0 million of revolving loans. The remaining $61.1 million is being used for general corporate purposes.

 

We believe that our existing cash balances, cash flows from operations and available borrowings under our senior credit facilities of $50.0 million will provide sufficient cash resources to meet our projected operating and other cash requirements for the next twelve months. An event of default under any debt instrument, if not cured or waived, could have a material adverse effect on us. We may require capital sooner than currently expected. We cannot assure you that additional financing will be available when we need it or, if available, that it will be available on satisfactory terms. In addition, the terms of our senior credit facilities and senior subordinated notes significantly reduce our ability to incur additional debt. Failure to obtain any such required additional financing could have a material adverse effect on our company.

 

ITEM 3.   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

For quantitative and qualitative disclosures about market risks affecting us, see Item 7A “Quantitative Disclosure About Market Risk” of our Annual Report on Form 10-K for the year ended December 31, 2002. Our exposure to market risks has not changed materially since December 31, 2002.

 

ITEM 4.   CONTROLS AND PROCEDURES

 

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-14 of the Securities Exchange Act of 1934 (the “Exchange Act”). Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective, as of September 30, 2003, in timely alerting them to material information relating to our company (including its consolidated subsidiaries) required to be included in our Exchange Act filings.

 

There have been no changes in our internal controls over financial reporting during the fiscal quarter ended September 30, 2003 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 

22


Table of Contents

PART II.    OTHER INFORMATION

 

ITEM 1.   LEGAL PROCEEDINGS

 

We are not involved in any legal proceedings the outcome of which we believe would have a material adverse effect on our business, financial condition or results of operations. From time to time, however, we are involved in claims that arise in the ordinary course of business, and we maintain insurance that we believe to be adequate to cover these claims.

 

ITEM 2.   CHANGES IN SECURITIES AND USE OF PROCEEDS

 

Not applicable

 

ITEM 3.   DEFAULTS UPON SENIOR SECURITIES

 

Not applicable

 

ITEM 4.   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

None

 

ITEM 5.   OTHER INFORMATION

 

Not applicable

 

ITEM 6.   EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K

 

  2.1

   Amended and Restated Agreement and Plan of Merger of ChipPAC, Inc., a California corporation, and ChipPAC, Inc., a Delaware corporation.**

  2.2

   Agreement and Plan of Recapitalization and Merger, dated as of March 13, 1999, by and among Hyundai Electronics Industries Co., Ltd., Hyundai Electronics America, ChipPAC, Inc. and ChipPAC Merger Corp.*

  2.3

   First Amendment to Agreement and Plan of Recapitalization and Merger, dated as of June 16, 1999 by and among Hyundai Electronics Industries Co., Ltd., Hyundai Electronics America, ChipPAC, Inc. and ChipPAC Merger Corp.*

  2.4

   Second Amendment to Agreement and Plan of Recapitalization and Merger, dated as of August 5, 1999, by and among Hyundai Electronics Industries Co., Ltd., Hyundai Electronics America, ChipPAC, Inc. and ChipPAC Merger Corp.*

  3.1

   Amended and Restated Certificate of Incorporation of ChipPAC, Inc.**

  3.2

   Amended and Restated By-Laws of ChipPAC, Inc.**

  4.1

   Specimen certificate for ChipPAC, Inc. Common Stock.**

10.1

   Credit Agreement, dated as of August 5, 1999, as amended and restated as of June 30, 2000, by and among ChipPAC International Company Limited, ChipPAC, Inc., the Lenders listed therein and Credit Suisse First Boston, as Administrative Agent, Sole Lead Manager and Collateral Agent.*

10.2

   Guaranty, dated as of August 5, 1999, by and among ChipPAC, Inc. and certain subsidiaries of ChipPAC, Inc., in favor of Credit Suisse First Boston (incorporated by reference to Exhibit 4.5 of the Company’s registration statement on Form S-3 (Registration No. 333-69704)).

10.3

   Amendment No. 1 to Amended and Restated Credit Agreement, dated as of March 13, 2001, by and among ChipPAC International Company Limited, ChipPAC, Inc., the Lenders listed therein and Credit Suisse First Boston, as Administrative Agent, Sole Lead Manager and Collateral Agent (incorporated by reference to Exhibit 10.1 to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2002 (No. 000-31173)).

 

23


Table of Contents
10.4    Amendment No. 2 to Amended and Restated Credit Agreement, as amended, dated as of December 31, 2001 by and among ChipPAC International Company Limited, ChipPAC, Inc., the Lenders listed therein and Credit Suisse First Boston, as Administrative Agent and Collateral Agent (incorporated by reference to Exhibit 10.1 to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2001 (No. 000-31173)).
10.5    Amendment No. 3 to Amended and Restated Credit Agreement, as amended, dated as of December 31, 2001 by and among ChipPAC International Company Limited, ChipPAC, Inc., the Lenders listed therein and Credit Suisse First Boston, as Administrative Agent and Collateral Agent (incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K (No. 000-31173)).
10.6    Amendment No. 4 to Amended and Restated Credit Agreement, as amended, dated as of May 17, 2002 by and among ChipPAC International Company Limited, ChipPAC, Inc, the Lenders listed therein and Credit Suisse First Boston, as Administrative Agent and Collateral Agent. (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended September 30, 2002).
10.7    Subsidiary Guaranty Agreement, dated as of August 5, 1999, by and among ChipPAC Korea Company Ltd., ChipPAC Limited, ChipPAC (Barbados) Ltd., ChipPAC Luxembourg S.a.R.L., ChipPAC Liquidity Management Hungary Limited Liability Company and ChipPAC International Company Limited, in favor of Firstar Bank of Minnesota, N.A.*
10.7.1    Subsidiary Guaranty Agreement, dated as of October 12, 2001, by ChipPAC Malaysia Sdn. Bhd, in favor of U.S. Bank, N.A.(incorporated by reference to Exhibit 4.7 of the Company’s registration statement on Form S-3 (Registration No. 333-69704)).
10.8    Amended and Restated Registration Agreement, dated as of August 5, 1999, by and among ChipPAC, Inc. the Hyundai Group (as defined therein), the Bain Group (as defined therein), the SXI Group (as defined therein), Intel Corporation, ChipPAC Equity Investors LLC, and Sankaty High Yield Asset Partners, L.P.*
10.8.1    Amendment No. 1 to Amended and Restated Registration Agreement, dated as of June 30, 2000, by and among ChipPAC, Inc., Sapphire Worldwide Investments, Inc., the Bain Stockholders (as defined therein) and SXI Group LLC.**
10.8.2    Form of Amendment No. 2 to Amended and Restated Registration Agreement, dated as of July 13, 2000, by and among ChipPAC, Inc., Qualcomm Incorporated, SXI Group LLC and the Bain Shareholders (as defined therein).**
10.8.3    Form of Amendment No. 3 to Amended and Restated Registration Agreement, dated as of August 2, 2000, by and among ChipPAC, Inc., Bain Capital, Inc., SXI Group LLC and the Bain Shareholders (as defined therein).**
10.9    Transition Services Agreement, dated as of August 5, 1999, by and among Hyundai Electronics Industries Co., Ltd., Hyundai Electronics America, ChipPAC, Inc., ChipPAC Korea Company Ltd., Hyundai Electronics Company (Shanghai) Ltd., ChipPAC Assembly and Test (Shanghai) Company Ltd., ChipPAC Barbados Limited and ChipPAC Limited.*
10.10    Lease Agreement, dated as of June 30, 1998, by and between Hyundai Electronics Industries Co., Ltd. and ChipPAC Korea Ltd.*
10.10.1    Amendment Agreement, dated September 30, 1998, to Lease Agreement, dated June 30, 1998, by and between Hyundai Electronics Industries Co., Ltd. and ChipPAC Korea Ltd.*
10.10.2    Amendment Agreement 2, dated September 30, 1999, to Lease Agreement, dated June 30, 1998, by and between Hyundai Electronics Industries Co., Ltd. and ChipPAC Korea Ltd.*
10.11    Agreement Concerning Supply of Utilities, Use of Welfare Facilities and Management Services for Real Estate, dated as of June 30, 1998, by and between Hyundai Electronics Industries Co., Ltd. and ChipPAC Korea Ltd.*
10.12    Service Agreement, dated as of August 5, 1999, by and between Hyundai Electronics Industries Co., Ltd. and ChipPAC Limited.+*
10.13    Sublease Agreement, dated as of May 1, 1998, by and between Hyundai Electronics America and ChipPAC, Inc.*
10.14    Employment letter agreement, dated as of January 10, 2003 between ChipPAC, Inc. and Robert Krakauer. (Incorporated by Reference to the Company’s Annual Report on Form 10-K for the period December 31, 2002)

 

24


Table of Contents
10.15    Employment letter agreement, dated as of January 13, 2003 between ChipPAC, Inc. and Patricia McCall. (Incorporated by Reference to the Company’s Annual Report on Form 10-K for the period December 31, 2002)
10.16    Employment Agreement, dated as of October 1, 1999, between ChipPAC, Inc. and Dennis McKenna.*
10.17    ChipPAC, Inc. 1999 Stock Purchase and Option Plan.*
10.18    ChipPAC, Inc. 2000 Equity Incentive Plan.**
10.19    ChipPAC, Inc. 2000 Employee Stock Purchase Plan.**
10.20    Form of Key Employee Purchased Stock Agreement.*
10.20.1    Form of Key Employee Purchased Stock Agreement (with Loan).*
10.21    Form of Employee Restricted Stock Agreement.*
10.22    Form of Directors Tranche I Stock Option Agreement.*
10.23    Form of Employees Tranche I Stock Option Agreement.*
10.24    Form of Tranche II Stock Option Agreement.*
10.25    Indenture, dated as of July 29, 1999, by and among ChipPAC International Limited, ChipPAC Merger Corp. and Firstar Bank of Minnesota, N.A., as trustee.*
10.26    First Supplemental Indenture, dated as of August 5, 1999, by and among ChipPAC International Company Limited, ChipPAC, Inc. and Firstar Bank of Minnesota, N.A., as trustee.*
10.27    12.75% Senior Subordinated Notes Due 2009.*
10.28    Form of Series B 12.75% Senior Subordinated Notes Due 2009.*
10.29    Intellectual Property Rights Agreement, entered into as of June 30, 2000, by and between Intersil Corporation and ChipPAC Limited.**
10.30    Supply Agreement, entered into as of June 30, 2000, by and between Intersil Corporation and ChipPAC Limited.**
10.31    Employment letter agreement, dated as of November 15, 1999 between ChipPAC, Inc. and Robert Krakauer (incorporated by reference to the Company’s annual report on Form 10-K for the period December 31, 2000).
10.32    Employment letter agreement, dated as of October 4, 2000 between ChipPAC, Inc. and Richard Freeman (incorporated by reference to the Company’s annual report on Form 10-K for the year ended December 31, 2001).
10.33    Employment letter agreement, dated as of October 9, 2000 between ChipPAC, Inc. and Patricia McCall (incorporated by reference to the Company’s annual report on Form 10-K for the year ended December 31, 2001).
10.34    Indenture, dated as of June 15, 2001, by and between ChipPAC, Inc. and Firstar Bank, N.A. as trustee (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2001).
10.35    Registration Rights Agreement, dated June 22, 2001, by and between ChipPAC International Company Limited and Citicorp Capital Investors Limited (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2001).
10.36    Registration Rights Agreement, dated June 22, 2001, by and between ChipPAC, Inc. and Citicorp Mezzanine III, L.P. (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2001).

 

25


Table of Contents
10.37    Patent and Technology License Agreement, dated as of August 5, 1999, by and between Hyundai Electronics Industries, Co., Ltd. and ChipPAC Limited (incorporated by reference to the Company’s annual report on Form 10-K for the year ended December 31, 2001). +
10.38    Amendment No. 5 to Amended and Restated Credit Agreement, as amended, dated as of May 19,2003 by and among ChipPAC International Company Limited, ChipPAC, Inc., the Lenders listed therein and Credit Suisse First Boston, as Administrative Agent and Collateral Agent (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2003).
10.39    Registration Rights Agreement, dated March 28, 2003, by and between ChipPAC Inc. and Lehman Brothers Inc. (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2003).
10.40    Indenture, dated as of May 28, 2003, by and between ChipPAC, Inc. and U.S. Bank National Association, as trustee. (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2003).
10.41    Settlement Agreement and General Release, dated as of September 26, 2003, between Richard Freeman and ChipPAC, Inc.
21.1    Subsidiaries of ChipPAC, Inc., ChipPAC International Company Limited, ChipPAC (Barbados) Ltd., ChipPAC Limited, ChipPAC Liquidity Management Limited Liability Company, ChipPAC Luxembourg S.a.R.L. and ChipPAC Korea Company Ltd. (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended on June 30, 2002).
31.1    Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2    Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1    Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2    Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
99.1    Risk Factors (incorporated by reference to the Company’s annual report on Form 10-K for the year ended December 31, 2002).

*   Incorporated by reference to the Company’s Form S-4 (No. 333-91641).

 

**   Incorporated by reference to the Company’s Form S-1 (No. 333-39428).

 

+   Confidential treatment has been granted as to certain portions of these exhibits, which are incorporated by reference.

 

  (b)   Reports on Form 8-K.

 

On July 31, 2003, we furnished a Current Report on Form 8-K to the SEC, reporting our earnings and including the Company’s press release announcing financial results for the three and six month periods ended June 30, 2003.

 

26


Table of Contents

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, as of November 12, 2003.

 

CHIPPAC, INC.

(Registrant)

/s/    ROBERT KRAKAUER

ROBERT KRAKAUER

Senior Vice President and Chief Financial Officer

/s/    MICHAEL G. POTTER

MICHAEL G. POTTER

Vice President, Controller and Chief Accounting Officer

 

27